12 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

QMS LAMOTRIGINE ASSAY (REAGENTS), CALIBRATORS & CONTROLS

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

PB560 VENTILATOR

FDA Adverse Event
Malfunction ·COVIDIEN·Product code CBK·August 22, 2011

OCU-FLEX-49 SPHERICAL, TORIC, ASPHERICAL AND TORIC ASPHERICAL (HIOXIFILCON B) SOFT CONTACT LENSES FOR DAILY WEAR

FDA 510(k)
FDA Class 2 ·Ophthalmic

ROCHE COBAS TAQMAN ANALYZER

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

PB560 VENTILATOR X1

FDA Adverse Event
Malfunction ·NELLCOR PURITAN BENNETT·Product code CBK·April 20, 2011

INFINION CX

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·March 12, 2022

HOLDING SLEEVE-LONG FOR MATRIX

FDA Adverse Event
Malfunction ·SYNTHES MONUMENT·Product code LXH·April 17, 2013

GO BED PLUS

FDA Adverse Event
Malfunction ·STRYKER MEDICAL·Product code FNL·April 11, 2011

9617604-2008-00081

FDA Adverse Event
Injury ·Product code CBH·June 13, 2008

AXON ECLIPSE CONTROLLER

FDA Adverse Event
Injury ·MEDTRONIC XOMED, INC·Product code GWF·October 4, 2013

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

FDA Enforcement
Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015